PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

36,672 stories, page 162 of 612

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

First participant dosed in the PRECISE-HD trial of pridopidine

HDBuzzOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Congressional Report Exposes How Chemical Abortion Drug Companies Endanger Mothers

townhall.comOriginal source
🇺🇸Industryir.codexis.comTier 1 · Company source

Codexis to Participate in Cantor Global Healthcare Conference 2026

CodexisOriginal source
🇩🇪Researchuni-heidelberg.deTier 2 · Direct publisher

Cells Have an Early-Warning System for Stress in Mitochondria

Heidelberg UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharma's Next AI Problem Is Authority

PharmTech.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Egyptian pharmaceutical firm developing Ebola vaccine

The New ArabOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eascra Biotech Awarded $7.96 Million NASA InSPA Phase 2 Contract to Advance Space-Manufactured Nanomedicine

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eascra Biotech Appoints Chief Scientific Officer to Lead Commercialization Push

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism

The Manila TimesOriginal source
🇯🇵Researchkyoto-u.ac.jpTier 2 · Direct publisher

Kyoto Summer Program 2026 concludes

Kyoto UniversityOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

pro+ Flat Deck Wide W/O X-Ray

The UDI label for model p7924a13 incorrectly states the product description as "Pro+ 40 MRS surface...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Cardinal Health Gynaecology Robotics and Endoscopy Packs

Cardinal Health was recently informed of a medical device recall from Stryker concerning the StrykeF...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Automated Impella Controller (AIC)

Abiomed has initiated a voluntary medical device recall (removal) after identification of an increas...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Apo-Semaglutide Injection : Incorrect dose display

The affected lot may display a 2 mg dose in the dose window and deliver a 2 mg dose instead of the e...

Health Canada Recalls and Safety AlertsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

About 160 adults will test MBX Biosciences’ once-weekly hormone replacement

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eascra Biotech Appoints Chief Scientific Officer to Lead Commercialization Push

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Guggenheim raises Amylyx stock price target on financing, trial data

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amgen TEZSPIRE Phase 3 Trial Shows EoE Improvements

grafa.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ASNC2026 to Showcase Pivotal Phase 3 Trials Advancing Cardiac Amyloidosis Diagnosis and Treatment

EIN NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Strategies for scaling complex next-generation biologics

European Pharmaceutical ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial

The Manila TimesOriginal source
🇺🇰Researchnews.cancerresearchuk.orgTier 2 · Direct publisher

Breaking down barriers to cervical screening – the evidence for HPV self-sampling

Cancer Research UKOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Corvus Pharmaceuticals Publishes Blood Data Showing Soquelitinib Activity in T Cell Lymphoma and Supporting Ongoing PTCL, Atopic Dermatitis Trials

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eyconis initiates first-in-human wet AMD trial on anti-VEGF therapy

Glance by Eyes On EyecareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cancer Drug Sales Power Up Kelun-Biotech’s Profit Engine

BenzingaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves Pancreatic Cancer Pill That Nearly Doubles Survival Time

MindBodyGreenOriginal source
🇪🇸Regulatoryaemps.gob.esTier 1 · Regulatory source

La AEMPS informa de un posible fallo en la fijación interna de la batería en determinados dispositivos de comunicación aumentativa y alternativa TD Navio Midi y TD Navio Maxi

AEMPS (Spain)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

The FDA's Trust Issue With China

PharmTech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Countdown to BIOHK2026: World-Class Biotech Convention Prepares to Host Global Pavilions, Multi-Track Forums, and Signature Executive Networking

aap.com.auOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Consun Pharmaceutical Group (SEHK:1681) Stock Draws Focus To Margin Strength And Yield

simplywall.stOriginal source
🇺🇸Devicesinvestors.bd.comTier 1 · Company source

BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation

Becton Dickinson (BD)Original source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

DHSC spending over £500

This series brings together all documents relating to Department of Health and Social Care (DHSC) sp...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

DHSC: spending over £500, July 2026

Department of Health and Social Care spending by electronic purchasing card solution (ePCS), over £5...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Alnylam’s heart drug troubles take center stage at a cardiology conference

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Policies can unlock medicinal plant biotech innovation

University World NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Full Path of Drug Development, and Why So Few Drugs Make It: Q&A with Dr. Ying Huang

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rare disease at FDA: two frameworks, one queue

The Pharma LetterOriginal source
🇺🇰Researchsphr.nihr.ac.ukTier 2 · Direct publisher

Inclusive Neighbourhood Health

NIHR School for Public Health ResearchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biovica Enters Master Services Agreement With Biotech Co

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

3 govt office canteens shut in Goa after FDA finds structural, hygiene lapses

The Economic TimesOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Parents urged to vaccinate children at the right time to protect them

Latest data shows signs that vaccine uptake by the time children start primary school is stabilising...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Childhood vaccination coverage: provisional monthly data for England

Monthly data and commentary on coverage achieved by the UK childhood vaccination programme in Englan...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Influenza: the green book chapter

Influenza immunisation information including updates for public health professionals.

UK Health Security AgencyOriginal source
🇩🇪Researchklinikum.uni-heidelberg.deTier 2 · Direct publisher

Universität gratuliert Ausgründung zu erfolgreicher Finanzierungsrunde

Universitätsklinikum HeidelbergOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many

The New York TimesOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Flu vaccination programme 2026 to 2027: healthcare practitioners

Guidance for healthcare practitioners on the national influenza immunisation programme 2026 to 2027.

UK Health Security AgencyOriginal source
🇩🇪Mediacharite.deTier 2 · Direct publisher

Zelltherapie bei schwerer rheumatoider Arthritis erfolgreich

Charité - Universitätsmedizin Berlin (EN)Original source
🇩🇪Researchcharite.deTier 2 · Direct publisher

Cell therapy successful in treating severe rheumatoid arthritis

Charité - Universitätsmedizin Berlin (EN)Original source
🇪🇸Researchcrg.euTier 2 · Direct publisher

The glue that holds the body together also helps swallow dead cells

CRG Barcelona GenomicsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Indonesia Salicylic Acid Pharmaceutical - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA sets PDUFA review for Nicox’ NCX 470

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 2 · Trade media

RevMed’s pancreatic cancer drug breezes through with swift approval

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Developing a fit-for-purpose release testing strategy for ADCs

European Pharmaceutical ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Huawei plans for more AI pharma tie-ups, says healthcare president

The Mighty 790 KFGOOriginal source
🌍discoverynews.google.comTier 2 · Trade media

A bill is supposed to protect U.S. biotech from Chinese competition. But there’s a loophole

STATOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

UKHSA ad hoc statistical publications

UK Health Security Agency additional statistical analyses not included in our standard official stat...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Cover of vaccination evaluated rapidly (COVER) programme: quality and methodology information

Quality and methodology information (QMI) for the COVER programme quarterly and annual childhood vac...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Pre-release access lists: Cover of vaccination evaluated rapidly (COVER) programme annual reports

Lists of those receiving pre-release access to UK Health Security Agency cover of vaccination evalua...

UK Health Security AgencyOriginal source